Table 1.
CD(n = 30) | UC(n = 30) | controls (n = 30) | |
---|---|---|---|
Male (n, (%)) | 19 (63.3) | 16 (53.3) | 13 (43.3) |
Age(years, ) | 37.4 ± 12.5 | 47.9 ± 17.1 | 43 ± 14.9 |
BMI (kg/m2, ) | 21.4 ± 3.6 | 20.6 ± 3.0 | 22.1 ± 2.7 |
Smoking(n, (%)) | 4(13.3) | 4(13.3) | 5(16.7) |
Alcohol(n, (%)) | 4(13.3) | 3(10.0) | 5(16.7) |
hsCRP(mg/L, Me(Q1,Q3)) | 6.36 (2.02,12.45)* | 3.91 (0.61,18.83) * | 1.57 (0.00,3.24) |
ESR(mm/h, Me(Q1,Q3)) | 14.5 (4.7,34.0) | 13.5(4.7,26.5) | - |
TG(mmol/L, Me(Q1,Q3)) | 1.08 (0.84,1.22) | 0.98 (0.67,1.51) | 1.03 (0.93,1.41) |
TC (mmol/L, Me(Q1,Q3)) | 3.79 (3.49,4.34) | 4.08 (3.46,4.76) | 3.28 (2.98,2.68) |
LDL (mmol/L, Me(Q1,Q3)) | 2.20 (1.86,2.56) | 2.20 (1.78,2.75) | 2.22 (1.88,2.99) |
Hb (g/L, Me(Q1,Q3)) | 131 (119,147) | 131 (117,145) | 139 (131,147) |
FC-positive (n, (%)) | 13 (43.3) | 18 (60.0) | - |
CDAI/Mayo score(Me(Q1,Q3)) | 217.8(200.7,235.0) | 9(7,10) | |
Lesion sites (n, (%)) | |||
L1/E1 | 4 (13.3) | 2 (6.7) | - |
L2/E2 | 6 (20.0) | 12 (40.0) | - |
L3/E3 | 20 (66.7) | 16 (53.3) | - |
Disease behavior (n (%)) | |||
B1 | 13 (43.3) | - | - |
B2 | 15 (50.0) | - | - |
B3 | 2 (6.7) | - | - |
* means p < 0.05